- Published
- 22 November 2022
- Journal article
SARS-CoV-2-specific nasal IgA wanes 9 months after hospitalisation with COVID-19 and is not induced by subsequent vaccination
- Authors
-
- Source
- EBioMedicine
Full text
Abstract
No abstract available.
Rights
This content is not covered by the Open Government Licence. Please see source record or item for information on rights and permissions.
Cite as
Liew, F., Talwar, S., Cross, A., Willett, B., Scott, S., Logan, N., Siggins, M., Swieboda, D., Sidhu, J., Efstathiou, C., Moore, S., Davis, C., Mohamed, N., Nunag, J., King, C., Thompson, A., Rowland-Jones, S., Docherty, A., Chalmers, J., Ho, L., Horsley, A., Raman, B., Poinasamy, K., Marks, M., Kon, O., Howard, L., Wootton, D., Dunachie, S., Quint, J., Evans, R., Wain, L., Fontanella, S., de Silva, T., Ho, A., Harrison, E., Baillie, J., Semple, M., Brightling, C., Thwaites, R., Turtle, L. & Openshaw, P. 2022, 'SARS-CoV-2-specific nasal IgA wanes 9 months after hospitalisation with COVID-19 and is not induced by subsequent vaccination', EBioMedicine. https://eprints.gla.ac.uk/286280/
Downloadable citations
Download HTML citationHTML Download BIB citationBIB Download RIS citationRISIdentifiers
- Repository URI
- https://eprints.gla.ac.uk/286280/